Mumbai (IE): Forty-year-old Swati Chiplunkar (name changed) was suffering from a rare type of cancer — cortical thymoma — a tumour located close to the heart which was difficult to operate. Oncologists predicted she would not live beyond three months. Swati and her husband decided that she would go for ayurvedic therapy.
She got herself admitted to Integrated Cancer Treatment and Research Centre at Wagholi, an ayurvedic hospital, where she went through Ayurvedic Shamana treatment, Panchkarma, dietary regulation and practised yoga. “She has been coping well for the past one-and-a-half years,” says Dr S P Sardeshmukh, director of the centre.
Swati is not alone. Prabhakar Limaye, 78, (name changed), who was diagnosed with liver cancer, completed cycles of chemotherapy in 2002 and decided to get enrolled in the ayurveda hospital’s integrated cancer treatment project. “For the last nine years, the cancer has not recurred,” says Sardeshmukh. Cancer is not a completely curable disease and we do accept this fact, says Sardeshmukh, who points out that ayurvedic treatment boosts immunity of patients and improves their lifestyle.
Rasayana and Panchakarma treatment has proved to be useful in controlling the recurrence and progression of the disease and also increasing resistance against it in the future.
The Centre not only offers ayurvedic treatment, but has also integrated it with facilities of radiotherapy, chemotherapy, oncosurgery, and oncopathalogy. This unique approach at the Integrated Cancer Centre has now been recognised as “Centre of Excellence” by Department of AYUSH and received Grant-In-Aid by Department of Atomic energy, Department of AYUSH, Government of India & Sir Dorabaji Tata Trust for expansion of this centre. The Tata trust has donated Rs 7 crore for setting up a 50-bed hospital.
While 5,000 patients have been registered at the Centre for treatment, there are 60 IPD patients, Sardeshmukh explains.
The integrated cancer project is carried out jointly by Dr Arvind Kulkarni, ex- HOD, Radiation Oncology Dept, Bombay Hospital, Mumbai and Dr Sadanand Sardeshmukh, who set up the hospital at Wagholi.
Sardeshmukh said after confirmation of cancer by means of biopsy, scan and pathological investigations, patients are enrolled in the project and divided into 4 groups — A, B, C and D. Group A consists of newly diagnosed patients opting for ayurvedic treatment and have not taken the conventional treatments available.
Group B comprises those who show recurrence despite the conventional allopathy treatment, whereas Group C takes ayurvedic treatment along with other conventional allopathic treatment such as chemotherapy, radiotherapy and surgery. Group D is those who have taken allopathic treatment prior to 6 months or more and wish to undergo ayurvedic treatment as prevention.